To effectively promote your brand, it is important to have a message that stands out and a story that will capture the attention of your target audience. We have utilized oncology message benchmarks to study more than 30,000 interactions between oncologists and sales representatives for over 100 brands to understand what makes them tick.
Posts
In addition to becoming a Nasdaq-listed company, the focus of Elicio moving forward will be a therapeutic cancer vaccine candidate that targets mKRAS-driven tumors.
The clinical trial diversity puzzle: how can the industry do better? The industry has faced the lack of clinical trial diversity head-on by working to improve access to clinical trials. […]
The vision is three-fold: uncover disease biology with AI; use these insights to design the right molecules; determine the right patient population for clinical trial success.
Even as their clients are trying to make clinical trials more diverse and equitable, agencies are continuing their DE&I efforts to build a culture where diverse talent is welcomed.
Co-developed by J&J’s Janssen and AbbVie’s Pharmacyclics, ibrutinib stood out across several presentations at the 64th American Society of Hematology (ASH) annual meeting Saturday and Sunday.
Athira Pharma’s experimental Alzheimer’s therapy, fosgonimeton, continues to show signs of being able to improve cognition and function in patients.
The company is developing brain chip interfaces that it says could help disabled patients to move and communicate again, with Musk adding it will also target restoring vision.
World AIDS Day on December 1 is an opportunity for people worldwide to unite in the fight against HIV and AIDS. It’s also time to take stock, be honest, and realize that we still have work to do to protect our communities.
The investment would add capacity in research and development for manufacturing of active pharmaceutical ingredients (API), the main biologically active components of medicines, to supply its global clinical trials.
